Complete PepGuide: Your Ultimate Peptide Reference Manual

Welcome to PepGuide, the most comprehensive peptide reference guide available for researchers, biohackers, and health optimizers. PepGuide.xyz was built with one purpose: to serve as the canonical, evidence-informed hub for peptide science. Whether you are just beginning to explore the biochemistry of amino acid chains or you are a seasoned researcher building advanced stacking protocols, this peptide guide is designed to provide accurate, organized, and accessible information across every major category of research peptides. From growth hormone secretagogues to healing compounds, from cognitive peptides to anti-aging research tools, this guide covers the full landscape with the depth and clarity that serious researchers demand.

What Are Research Peptides? A Foundational Overview for the PepGuide

Peptides are short chains of amino acids linked together by peptide bonds. Depending on the length and sequence of the chain, a peptide can interact with specific receptors in the body to trigger a wide range of biological responses. Research peptides are synthesized versions of these compounds, designed to mimic or modulate naturally occurring biological signaling molecules. They are studied in laboratory settings for their potential applications in tissue repair, hormone regulation, cognitive function, immune modulation, and much more.

The distinction between endogenous peptides and synthetic analogs is important. Endogenous peptides are produced naturally within the body. Synthetic analogs are engineered to replicate or enhance the activity of those natural compounds. For example, Sermorelin is an FDA-referenced growth hormone releasing hormone (GHRH) analog that closely mirrors the activity of endogenous GHRH. Understanding this relationship between natural and synthetic peptides forms the foundation of all serious peptide research.

All peptides discussed in this peptide guide are classified as research chemicals. They are intended strictly for laboratory and scientific research purposes and are not intended for human consumption. Researchers should always operate within the legal and ethical frameworks governing their jurisdiction and institution.

Peptide Classification by Research Category: The PepGuide System

One of the most useful features of a well-structured peptide reference guide is clear classification by function. Peptides do not belong to a single category. Many compounds have overlapping mechanisms, but organizing them by primary research application allows researchers to navigate the field more efficiently. PepGuide uses the following primary classification system.

Growth Hormone Secretagogues

Growth hormone secretagogues (GHS) are peptides that stimulate the pituitary gland to release growth hormone. They are divided into two main subtypes: growth hormone releasing hormone (GHRH) analogs and growth hormone releasing peptides (GHRPs). These two classes work through different receptor pathways and are frequently studied together for their synergistic potential.

CJC-1295 is a widely studied GHRH analog. It is often paired with a GHRP to amplify growth hormone pulses. The CJC-1295 Ipamorelin stack is one of the most referenced growth hormone secretagogue combinations in the research literature, valued for its ability to produce sustained and clean growth hormone release with a favorable side effect profile. Ipamorelin itself is a selective GHRP that stimulates growth hormone release without significantly elevating cortisol or prolactin, which is a key differentiator from older GHRPs like GHRP-6 and GHRP-2.

GHRP-6 and GHRP-2 remain important benchmark compounds in growth hormone research. GHRP-6 is associated with significant appetite stimulation due to its action on ghrelin receptors, while GHRP-2 produces stronger growth hormone release but with more pronounced cortisol elevation. Comparing these compounds to newer selective GHRPs like Ipamorelin helps researchers understand the evolution of growth hormone secretagogue design.

Healing and Tissue Repair Peptides

BPC-157 (Body Protection Compound) is perhaps the most well-known healing peptide in current research circles. Derived from a protein found in gastric juice, BPC-157 has been studied for its regenerative effects on tendons, ligaments, muscle tissue, the gut lining, and the nervous system. Research published across multiple peer-reviewed sources suggests that BPC-157 promotes angiogenesis, accelerates wound closure, and modulates nitric oxide synthesis pathways.

TB-500 (a synthetic analog of Thymosin Beta-4) is the other cornerstone of tissue repair and healing research. While BPC-157 and TB-500 share overlapping applications in musculoskeletal repair research, they operate through distinct mechanisms. BPC-157 primarily influences growth factor expression and local tissue signaling, while TB-500 modulates actin regulation and promotes cell migration, which is critical for systemic healing responses. The BPC-157 and TB-500 stack is frequently discussed in the biohacker community as a dual-mechanism approach to accelerated tissue regeneration research.

Cognitive Enhancement and Nootropic Peptides

Selank is a heptapeptide with origins in Russian neuroscience research. It is derived from the immunomodulatory peptide tuftsin and has been studied for its anxiolytic, nootropic, and neuroprotective properties. Research from Russian academic institutions suggests that Selank may enhance memory consolidation, reduce anxiety-like behavior, and modulate serotonin and dopamine pathways. It represents an important category within this peptide reference guide: peptides developed outside the Western pharmaceutical pipeline that have significant scientific backing.

Anti-Aging and Longevity Peptides

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide studied primarily for its effects on telomere length and cellular aging. Research suggests that Epithalon activates telomerase, the enzyme responsible for maintaining telomere integrity, which has significant implications for cellular longevity research. Studies indexed in PubMed document its potential to extend cell lifespan in laboratory models and modulate melatonin secretion via the pineal gland.

Melanocortin System Peptides

PT-141 (Bremelanotide) is a melanocortin receptor agonist studied for its effects on sexual function and libido in both male and female research models. Unlike compounds that act on the vascular system, PT-141 acts centrally through the nervous system, specifically targeting melanocortin receptors in the brain. This mechanism of action makes it a unique research tool within the melanocortin system peptide category.

Growth Factor Peptides

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a modified analog of IGF-1 with an extended half-life compared to the native compound. It plays a central role in mediating the anabolic effects of growth hormone and is studied for its impact on muscle cell proliferation, differentiation, and metabolic signaling. IGF-1 LR3 is a technically complex compound that requires careful handling, precise reconstitution, and an understanding of its potent receptor binding affinity.

Peptide Pharmacokinetics: Half-Life, Receptor Binding, and Dosing Implications

Understanding pharmacokinetics is essential for any serious peptide researcher. The half-life of a peptide refers to the time it takes for the concentration of the compound in the body to reduce by half. This metric directly influences dosing frequency and administration timing in research protocols.

For example, native CJC-1295 without DAC (Drug Affinity Complex) has a half-life of approximately 30 minutes, requiring more frequent administration to sustain elevated growth hormone levels. CJC-1295 with DAC extends the half-life to several days by binding to albumin in the bloodstream. Ipamorelin has a relatively short half-life of approximately 2 hours, making it well-suited for pulse-based dosing strategies that mimic natural growth hormone secretion patterns.

Receptor binding affinity is the other critical pharmacokinetic variable. A peptide with high receptor binding affinity requires a lower effective dose but may also carry a higher risk of receptor desensitization with prolonged use. Peptides like BPC-157 appear to have pleiotropic effects through multiple receptor systems, which may explain their broad therapeutic research profile without significant receptor saturation concerns.

Bioavailability varies significantly depending on the administration route. Subcutaneous injection delivers the peptide into the fatty tissue layer beneath the skin, resulting in slower absorption and a more sustained plasma concentration curve. Intramuscular injection delivers the peptide directly into muscle tissue, resulting in faster absorption. Intranasal administration is used for certain peptides like Selank and offers a non-injectable delivery route with reasonable bioavailability for smaller peptide molecules. Each route has distinct implications for research protocol design.

Reconstitution and Storage: Handling Lyophilized Research Peptides

Most research peptides are supplied in lyophilized powder form, meaning they have been freeze-dried to remove moisture and extend shelf life. Before use in a research protocol, lyophilized powder must be reconstituted with an appropriate solvent. The standard reconstitution solution for research peptides is bacteriostatic water, which contains 0.9% benzyl alcohol as a preservative. This preservative prevents bacterial contamination and extends the usable life of the reconstituted peptide solution.

The reconstitution process requires careful technique. The bacteriostatic water should be introduced slowly along the interior wall of the vial rather than injected directly onto the lyophilized powder cake. This minimizes mechanical disruption of the peptide structure. The vial should then be gently swirled, never vigorously shaken, until the powder is fully dissolved. Shaking introduces air bubbles and can fragment delicate peptide chains, reducing the potency and reliability of the resulting solution.

Calculating the correct volume of bacteriostatic water for reconstitution is a critical step that determines the concentration of the final solution. For example, if a vial contains 5 mg of peptide and 2.5 mL of bacteriostatic water is added, the resulting concentration is 2 mg per mL or 2000 mcg per mL. This concentration figure is then used to calculate the volume required for each individual dose using a standard insulin syringe.

Storage conditions have a direct impact on peptide stability and research validity. Lyophilized, unreconstituted peptide vials should be stored in a freezer at approximately -20 degrees Celsius and kept away from light. Once reconstituted, peptide solutions should be stored in a refrigerator at 2 to 8 degrees Celsius and used within 30 days for optimal potency. Repeated freeze-thaw cycles should be avoided at all stages, as thermal cycling degrades peptide chains and reduces biological activity. Proper labeling of vials with the reconstitution date, concentration, and compound name is a basic but important research hygiene practice.

Peptide Stacking Protocols: Principles for Advanced Researchers

Peptide stacking refers to the practice of combining two or more peptides within the same research protocol to achieve complementary or synergistic biological effects. This is a well-established area of inquiry within the PepGuide framework, and understanding the principles behind rational stacking is essential before reviewing specific combinations.

The primary rationale for stacking is mechanistic complementarity. When two peptides act through distinct receptor pathways to produce related downstream effects, combining them can produce a more complete or robust response than either compound alone. The CJC-1295 and Ipamorelin stack is the clearest illustration of this principle. CJC-1295 acts on GHRH receptors to amplify the pituitary's growth hormone output, while Ipamorelin acts on ghrelin receptors to trigger independent growth hormone pulses. Together, they activate two separate arms of the growth hormone secretion cascade simultaneously.

A second stacking rationale is systemic versus local targeting. BPC-157 exerts strong local tissue repair effects at sites of injury or inflammation, while TB-500 operates systemically through actin modulation and cell migration pathways. Stacking these two compounds in a tissue repair research context is intended to provide both targeted local repair signaling and broader systemic regenerative support, addressing the healing process from two distinct angles.

Researchers building stacking protocols should also consider timing. Peptides with short half-lives that are administered in pulses, such as Ipamorelin or GHRP-6, are typically dosed at specific times relative to meals or sleep cycles to align with natural hormonal rhythms. Peptides with longer half-lives, such as CJC-1295 with DAC or IGF-1 LR3, have less strict timing requirements but still benefit from consistent scheduling to maintain stable plasma concentrations across the research period.

Cycle length and off-cycle periods are another dimension of stacking protocol design. Continuous administration of potent secretagogues over extended periods raises the theoretical concern of pituitary receptor desensitization. Many research frameworks include structured off-cycle periods, typically ranging from two weeks to one month following an eight-to-twelve week active research cycle, to allow receptor sensitivity to normalize before resuming the protocol.

Sourcing Research Peptides: Quality, Purity, and Verification Standards

The quality of research peptides varies dramatically across suppliers, and the integrity of any research protocol depends entirely on the purity and accuracy of the compounds being used. This section of the peptide guide outlines the verification standards that researchers should apply when evaluating potential peptide sources.

The gold standard for peptide purity verification is third-party testing via high-performance liquid chromatography (HPLC) and mass spectrometry (MS). HPLC analysis confirms the purity percentage of the compound, identifying any contaminants or degradation products. Mass spectrometry confirms the molecular weight and identity of the compound, verifying that what is labeled in the vial is actually what is present. Reputable research peptide suppliers will provide Certificates of Analysis (CoAs) from independent third-party laboratories for every batch of product they sell. Researchers should treat the absence of third-party CoAs as a disqualifying factor when evaluating a supplier.

Beyond analytical testing, researchers should evaluate suppliers on several additional criteria. Manufacturing transparency matters: suppliers who openly describe their synthesis methods, quality control processes, and laboratory standards are more trustworthy than those who provide no information about their production pipeline. Batch-specific documentation is preferable to generic CoAs that apply to an entire product line without linking to specific lot numbers.

Pricing is a useful but imperfect signal of quality. Peptides that are priced significantly below market rate often reflect compromises in raw material quality, synthesis purity, or analytical verification. However, high pricing alone does not guarantee quality. The presence of verifiable, batch-specific third-party testing documentation remains the most reliable quality indicator available to researchers.

Researchers should also be aware of the regulatory landscape governing peptide purchasing in their jurisdiction. In the United States, research peptides occupy a legal gray area when sold explicitly for research purposes and not for human consumption. Other jurisdictions may have stricter regulations governing the purchase, import, or possession of specific peptides. Staying current with applicable regulations is a non-negotiable component of responsible research practice and a core principle of the PepGuide sourcing framework.

Quick-Reference Peptide Dosing Table

The following table provides a high-level reference summary for commonly researched peptides. All figures are drawn from published research literature and community-documented protocols. This table is provided for informational and research organization purposes only and does not constitute dosing recommendations for human use.

Frequently Asked Questions: PepGuide Peptide Reference Guide